Toctino (TOCK-tee-no) is a new ORAL retinoid for severe hand eczema in adults

Toctino (TOCK-tee-no) is a new ORAL retinoid for severe hand eczema in adults. It's being marketed in Canada before the U.S.

It's ONLY for eczema that doesn't improve enough with high-potency topical steroids. Expect about half of these patients to have clear or almost clear eczema in about 3 months with the usual starting dose of Toctino (alitretinoin).

Recommend starting with 30 mg/day. A 10 mg cap will be out soon for patients who don't tolerate the higher dose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote